ES2103740T3 - Factor de crecimiento celular endotelialico, su aislamiento y su expresion. - Google Patents

Factor de crecimiento celular endotelialico, su aislamiento y su expresion.

Info

Publication number
ES2103740T3
ES2103740T3 ES90907823T ES90907823T ES2103740T3 ES 2103740 T3 ES2103740 T3 ES 2103740T3 ES 90907823 T ES90907823 T ES 90907823T ES 90907823 T ES90907823 T ES 90907823T ES 2103740 T3 ES2103740 T3 ES 2103740T3
Authority
ES
Spain
Prior art keywords
growth factor
factor
insulation
expression
cell growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90907823T
Other languages
English (en)
Inventor
Napoleone Ferrara
Denis Gospodarowicz
Jean Plouet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California Berkeley
University of California San Diego UCSD
Original Assignee
University of California Berkeley
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California Berkeley, University of California San Diego UCSD filed Critical University of California Berkeley
Application granted granted Critical
Publication of ES2103740T3 publication Critical patent/ES2103740T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)

Abstract

UN FACTOR DE CRECIMIENTO NUEVO, ESPECIFICO PARA LAS CELULAS ENDOTELIAS VASCULARES HA SIDO IDENTIFICADO EN UN MEDIO ACONDICIONADO CON CELULAS ESTRELLADAS FOLICULARES DERIVADAS DE BOVINOS. ESTE FACTOR, LLAMADO FACTOR DE CRECIMIENTO DERIVADO ESTRELLADO FOLICULAR (FSDGF) O FACTOR DE CRECIMIENTO ENDOTELIAL VASCULAR (VEGF), FUE PURIFICADO HASTA LA HOMOGENEIDAD MEDIANTE UNA COMBINACION DE COMATOGRAFIA DE EXCLUSION, LA CROMATOGRAFIA DE INTERCAMBIO DE IONES MONO S Y CROMATOGRAFIA HIDROFOBICA EN UNA COLUMNA HPLC DE FASE REVERSA C4. EL FACTOR TAMBIEN SE ENCUENTRA EN LA LINEA DE CELULA DE MURINA ATT-20. EL FSDGF, CON UN PESO MOLECULAR DE UNOS 43.000 DALTON, FUE CARACTERIZADO COMO UNA GLICOPROTEINA COMPUESTA DE DOS SUBNIDADES HOMOLOGAS CON UN PESO MOLECULAR DE UNOS 23.000 DALTONS.
ES90907823T 1989-03-24 1990-03-22 Factor de crecimiento celular endotelialico, su aislamiento y su expresion. Expired - Lifetime ES2103740T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32818189A 1989-03-24 1989-03-24
US34616589A 1989-05-02 1989-05-02
US36023589A 1989-06-01 1989-06-01

Publications (1)

Publication Number Publication Date
ES2103740T3 true ES2103740T3 (es) 1997-10-01

Family

ID=27406587

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90907823T Expired - Lifetime ES2103740T3 (es) 1989-03-24 1990-03-22 Factor de crecimiento celular endotelialico, su aislamiento y su expresion.

Country Status (12)

Country Link
EP (1) EP0464155B1 (es)
JP (1) JP3549202B2 (es)
AT (1) ATE152626T1 (es)
AU (1) AU647737B2 (es)
CA (1) CA2050318C (es)
DE (1) DE69030660T2 (es)
DK (1) DK0464155T3 (es)
ES (1) ES2103740T3 (es)
IL (1) IL93846A0 (es)
NZ (1) NZ233067A (es)
PT (1) PT93560B (es)
WO (1) WO1990011084A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7300791B2 (en) 1989-05-12 2007-11-27 Genentech, Inc. Production of vascular endothelial cell growth factor and DNA encoding same
US5332671A (en) * 1989-05-12 1994-07-26 Genetech, Inc. Production of vascular endothelial cell growth factor and DNA encoding same
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
CZ291047B6 (cs) * 1992-10-28 2002-12-11 Genentech, Inc. Farmaceutický prostředek obsahující antagonisty faktoru růstu vaskulárních endoteliálních buněk
CN1701814A (zh) * 1992-11-13 2005-11-30 马克斯普朗克科学促进协会 作为血管内皮生长因子受体的f1k－1
US7030083B2 (en) 1998-09-09 2006-04-18 University Of Washington Treatment of eclampsia and preeclampsia
EP1109571B1 (en) 1998-09-09 2004-03-03 Scios Inc. Methods of treating salt-dependent hypertension
US6783953B1 (en) 1998-12-22 2004-08-31 Janssen Pharmaceutica N.V. Vascular endothelial growth factor-X
US7026462B2 (en) 2000-12-07 2006-04-11 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins
US7067317B2 (en) 2000-12-07 2006-06-27 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4456550A (en) * 1982-11-22 1984-06-26 President And Fellows Of Harvard College Vascular permeability factor
US5008196A (en) * 1987-08-21 1991-04-16 Monsanto Company Stimulation of endothelial cell growth
US5240848A (en) * 1988-11-21 1993-08-31 Monsanto Company Dna sequences encoding human vascular permeability factor having 189 amino acids
US5332671A (en) * 1989-05-12 1994-07-26 Genetech, Inc. Production of vascular endothelial cell growth factor and DNA encoding same
EP0399816B1 (en) * 1989-05-24 1995-12-20 Merck & Co. Inc. Purification and characterization of a glioma-derived growth factor
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor

Also Published As

Publication number Publication date
IL93846A0 (en) 1990-12-23
EP0464155A1 (en) 1992-01-08
ATE152626T1 (de) 1997-05-15
JPH04504262A (ja) 1992-07-30
EP0464155A4 (en) 1992-05-06
DE69030660T2 (de) 1997-09-25
CA2050318A1 (en) 1990-09-25
PT93560B (pt) 1996-08-30
JP3549202B2 (ja) 2004-08-04
DE69030660D1 (de) 1997-06-12
AU5565990A (en) 1990-10-22
PT93560A (pt) 1990-11-07
NZ233067A (en) 1993-05-26
DK0464155T3 (da) 1997-11-17
AU647737B2 (en) 1994-03-31
CA2050318C (en) 2011-04-12
EP0464155B1 (en) 1997-05-07
WO1990011084A1 (en) 1990-10-04

Similar Documents

Publication Publication Date Title
ATE128715T1 (de) Polypeptide induzierende faktoren in knochen und knorpel.
ES2103740T3 (es) Factor de crecimiento celular endotelialico, su aislamiento y su expresion.
ES2094159T3 (es) Produccion de factor de crecimiento de celulas endoteliales vasculares.
ES2156893T3 (es) Polimeros biodegradables de trasplante de celulas.
ES2124685T3 (es) Variantes del inhibidor de la tripsina pancreatica bovina, su produccion y uso.
DK0863776T3 (da) Et biologisk materiale, der omfatter en effektiv kultur af knoglemarvsstamceller, der er differentieret delvist eller fuldstændigt til bindevævsceller og en tredimensionel biokompatibel og biologisk nedbrydelig matrix bestående af en hyaluronsyrederivat
ES2151463T1 (es) Constructos de adn para la modificacion de la activacion y expresion de genes endogenos.
PT720482E (pt) Prosaposina e peptidos derivados da citocina utilizados como agentes
RU94045952A (ru) Домен ингибитора протеазы, днк, вектор, клетка, способ получения ингибитора протеазы, фармацевтическая композиция, применение домена
DK116691D0 (da) Polypeptid-polymerkonjugater, der er aktive i saarheling
EP0653940A4 (en) GLIALMITOGENIC FACTORS, THEIR PRODUCTION AND USE.
DK0502172T3 (da) Biomateriale på basis af kollagen og materialets anvendelser
ES2151921T3 (es) Analogo de dolastatina.
ES2088006T3 (es) Composiciones farmaceuticas osteoinductivas.
ES2059361T3 (es) Complejo de proteinas recombinantes que tiene actividad de factor viii:c su produccion y uso.
RU94036776A (ru) Домен ингибитора протеазы, днк, вектор, клетка, способ получения ингибитора протеазы, фармацевтическая композиция, применение домена ингибитора протеазы
ATE125268T1 (de) Säureempfindliche subeinheit eines insulinähnlichen wachstumfaktors-bindeprotein- komplexes.
DE69130981D1 (de) Expression von makrophagen-induzierbaren proteinen (mips) in hefezellen
DE69132530D1 (de) Heparin bindendes mitogen mit homologie zum epidermis wachstumsfaktor (egf)
ATE107665T1 (de) Proteaseresistenter pdgf und dessen verwendungen.
ES362475A1 (es) Procedimiento de preparacion de 17-alfa-monoesteres de 11- beta 17-alfa, 21-trihidroxiesteroides.
SE8403656D0 (sv) Anordning for att fylla en kartong
ATE168414T1 (de) Aprotininanaloga
NO951277L (no) Desulfatohirudin med höy molekylvekt
ES2063161T3 (es) Proteinas modificadas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 464155

Country of ref document: ES